Mechanisms of action of currently used antiseizure drugs

Graeme J. Sills; Michael A. Rogawski

doi:10.1016/j.neuropharm.2020.107966

journal article May 01, 2020

Mechanisms of action of currently used antiseizure drugs

Graeme J. Sills Michael A. Rogawski

Neuropharmacology Vol. 168 pp. 107966 · Elsevier BV

View at Publisher Save 10.1016/j.neuropharm.2020.107966

Topics

No keywords indexed for this article. Browse by subject →

References

197

[1]

Balenga "Pharmacology, signaling and physiological relevance of the G protein-coupled receptor 55" Adv. Pharmacol. (2011) 10.1016/b978-0-12-385952-5.00004-x

[2]

Baulac "Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial" Lancet Neurol. (2017) 10.1016/s1474-4422(16)30292-7

[3]

Baumann "Forced subunit assembly in α1β2γ2 GABAA receptors. Insight into the absolute arrangement" J. Biol. Chem. (2002) 10.1074/jbc.m207663200

[4]

Baumann "Individual properties of the two functional agonist sites in GABAA receptors" J. Neurosci. (2003) 10.1523/jneurosci.23-35-11158.2003

[5]

Belelli "Extrasynaptic GABAA receptors: form, pharmacology, and function" J. Neurosci. (2009) 10.1523/jneurosci.3340-09.2009

[6]

Bhaskaran "Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy" Exp. Neurol. (2010) 10.1016/j.expneurol.2010.01.021

[7]

Bjursell "Deletion of Gpr55 results in subtle effects on energy metabolism, motor activity and thermal pain sensation" PLoS One (2016) 10.1371/journal.pone.0167965

[8]

Borden "GABA transporter heterogeneity: pharmacology and cellular localization" Neurochem. Int. (1996) 10.1016/0197-0186(95)00158-1

[9]

Borden "Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1" Eur. J. Pharmacol. (1994) 10.1016/0922-4106(94)90089-2

[10]

Bowery "GABAB receptor pharmacology" Annu. Rev. Pharmacol. Toxicol. (1993) 10.1146/annurev.pa.33.040193.000545

[11]

Brill "Chronic valproic acid treatment triggers increased neuropeptide Y expression and signaling in rat nucleus reticularis thalami" J. Neurosci. (2006) 10.1523/jneurosci.5320-05.2006

[12]

Brodie "Combining antiepileptic drugs--rational polytherapy?" Seizure (2011) 10.1016/j.seizure.2011.01.004

[13]

Brodie "Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group" Epilepsy Res. (1997) 10.1016/s0920-1211(96)01007-8

[14]

Brohan "The role of GABA receptor agonists in anesthesia and sedation" CNS Drugs (2017) 10.1007/s40263-017-0463-7

[15]

Broicher "T-current related effects of antiepileptic drugs and a Ca2+ channel antagonist on thalamic relay and local circuit interneurons in a rat model of absence epilepsy" Neuropharmacology (2007) 10.1016/j.neuropharm.2007.05.030

[16]

Brunklaus "Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome" Brain (2012) 10.1093/brain/aws151

[17]

Carrier "Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression" Proc. Natl. Acad. Sci. U. S. A. (2006) 10.1073/pnas.0511232103

[18]

Carunchio "Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam" Epilepsia (2007) 10.1111/j.1528-1167.2006.00973.x

[19]

Catterall "Cellular and molecular biology of voltage-gated sodium channels" Physiol. Rev. (1992) 10.1152/physrev.1992.72.suppl_4.s15

[20]

Catterall "Structure and regulation of voltage-gated Ca2+ channels" Annu. Rev. Cell Dev. Biol. (2000) 10.1146/annurev.cellbio.16.1.521

[21]

Catterall "Forty years of sodium channels: structure, function, pharmacology, and epilepsy" Neurochem. Res. (2017) 10.1007/s11064-017-2314-9

[22]

Catterall "Structural basis for pharmacology of voltage-gated sodium and calcium channels" Mol. Pharmacol. (2015) 10.1124/mol.114.097659

[23]

Chatelier "Biophysical characterisation of the persistent sodium current of the Nav1.6 neuronal sodium channel: a single-channel analysis" Pflüg. Arch. (2010) 10.1007/s00424-010-0801-9

[24]

Chen "Cannabidiol: a new hope for patients with Dravet or Lennox-Gastaut syndromes" Ann. Pharmacother. (2019) 10.1177/1060028018822124

[25]

Chen "Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study" JAMA Neurol. (2018) 10.1001/jamaneurol.2017.3949

[26]

Chen "The α2δ-1-NMDA receptor complex Is critically involved in neuropathic pain development and gabapentin therapeutic actions" Cell Rep. (2018) 10.1016/j.celrep.2018.02.021

[27]

Chiara "Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor" J. Biol. Chem. (2013) 10.1074/jbc.m113.479725

[28]

Chincholkar "Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review" Br. J. Anaesth. (2018) 10.1016/j.bja.2018.02.066

[29]

Christie "Molecular and functional diversity of K+ channels" Clin. Exp. Pharmacol. Physiol. (1995) 10.1111/j.1440-1681.1995.tb02331.x

[30]

Consroe "Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice" Eur. J. Pharmacol. (1982) 10.1016/0014-2999(82)90264-3

[31]

Coulter "Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons" Ann. Neurol. (1989) 10.1002/ana.410250610

[32]

Persistent Sodium Current in Mammalian Central Neurons

W E Crill

Annual Review of Physiology 1996 10.1146/annurev.ph.58.030196.002025

[33]

Crowder "Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)" Proc. Natl. Acad. Sci. U. S. A. (1999) 10.1073/pnas.96.26.15268

[34]

Cunningham "Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro" Eur. J. Neurosci. (2004) 10.1111/j.1460-9568.2004.03625.x

[35]

Curatolo "mTOR dysregulation and tuberous sclerosis-related epilepsy" Expert Rev. Neurother. (2018) 10.1080/14737175.2018.1428562

[36]

Custer "Synaptic vesicle protein 2 enhances release probability at quiescent synapses" J. Neurosci. (2006) 10.1523/jneurosci.2699-05.2006

[37]

Czuczwar "The new generation of GABA enhancers. Potential in the treatment of epilepsy" CNS Drugs (2001) 10.2165/00023210-200115050-00001

[38]

Czuczwar "Pharmacodynamic interactions between antiepileptic drugs: preclinical data based on isobolography" Expert Opin. Drug Metabol. Toxicol. (2009) 10.1517/17425250802677826

[39]

Dailey "Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero Ca2+" Eur. J. Pharmacol. (1997) 10.1016/s0014-2999(97)83041-5

[40]

Deckers "Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed" Epilepsia (2000) 10.1111/j.1528-1157.2000.tb00111.x

[41]

Di Stefano "Pharmacological treatment of trigeminal neuralgia" Expert Rev. Neurother. (2017) 10.1080/14737175.2017.1370375

[42]

The Glutamate Receptor Ion Channels

Raymond Dingledine, Karin Borges, Derek Bowie et al.

Pharmacological Reviews 1999 10.1016/s0031-6997(24)01394-2

[43]

Dolphin "Calcium channel auxiliary α2δ and β subunits: trafficking and one step beyond" Nat. Rev. Neurosci. (2012) 10.1038/nrn3311

[44]

The α2δ subunits of voltage-gated calcium channels

Annette C. Dolphin

Biochimica et Biophysica Acta (BBA) - Biomembranes 2013 10.1016/j.bbamem.2012.11.019

[45]

Dooley "Ca2+ channel α2δ ligands: novel modulators of neurotransmission" Trends Pharmacol. Sci. (2007) 10.1016/j.tips.2006.12.006

[46]

Errington "The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels" Mol. Pharmacol. (2008) 10.1124/mol.107.039867

[47]

Farrant "Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors" Nat. Rev. Neurosci. (2005) 10.1038/nrn1625

[48]

Feng "Barbiturates require the N terminus and first transmembrane domain of the δ subunit for enhancement of α1β3δ GABAA receptor currents" J. Biol. Chem. (2010) 10.1074/jbc.m110.122564

[49]

Ferrendelli "Rational polypharmacy" Epilepsia (1995)

[50]

Ffrench-Mullen "Calcium current block by (–)-pentobarbital, phenobarbital, and CHEB but not (+)-pentobarbital in acutely isolated hippocampal CA1 neurons: comparison with effects on GABA-activated Cl– current" J. Neurosci. (1993) 10.1523/jneurosci.13-08-03211.1993

Showing 50 of 197 references

Cited By

426

The senescent niche hypothesis: microglial dysfunction and replacement strategies in drug-resistant epilepsy

Jingheng Wu, Miaomiao Li · 2026

Frontiers in Immunology

Neuronal K+-Cl- cotransporter KCC2 as a promising drug target for epilepsy treatment

Erin McMoneagle, Jin Zhou · 2023

Acta Pharmacologica Sinica

Metrics

426

Citations

197

References

Details

Published: May 01, 2020
Vol/Issue: 168
Pages: 107966
License: View

Authors

Department of Neurology, School of Medicine, University of California, Davis, Sacramento, CA 95817, USA.

Funding

ASD

Cite This Article

Graeme J. Sills, Michael A. Rogawski (2020). Mechanisms of action of currently used antiseizure drugs. Neuropharmacology, 168, 107966. https://doi.org/10.1016/j.neuropharm.2020.107966

Mechanisms of action of currently used antiseizure drugs

You May Also Like